Bruce Keyt, Chief Scientific Officer at IGM Biosciences, Inc. (IGMS), sold 35,000 shares at $20.34 ($681K) on 2022-09-08, disclosed to the SEC on 2022-09-08.
Open-market sale of $681k IGMS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.06 | 5,000 | $95K | 14.0% |
| 2 | $19.04 | 10,000 | $190K | 27.9% |
| 3 | $19.57 | 7,265 | $142K | 20.9% |
| 4 | $19.57 | 7,265 | $142K | 20.9% |
| 5 | $20.34 | 2,735 | $56K | 8.2% |
| 6 | $20.34 | 2,735 |
| $56K |
| 8.2% |
| Total | $19.47 avg | 35,000 | $681K | 100% |
| Filing → |
| IGMS | SELL | 2024-03-15 | $40K | — | Filing → |
| IGMS | SELL | 2023-12-15 | $44K | — | Filing → |
| IGMS | SELL | 2023-11-29 | $5K | — | Filing → |